Left ventricular remodeling and systolic deterioration in acute myocardial infarction: Findings from the Stent-PAMI study

Journal of Interventional Cardiology

Volumn 18, Issue 4, 2005, Pages 255-260

  Mattichak, Stephen J ^a   Harjai, Kishore J ^b   Dutcher, Jacob R ^a   Boura, Judith A ^a   Stone, Gregg ^c   Cox, David ^d   Brodie, Bruce R ^e   O'Neill, William W ^a   Grines, Cindy L ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b GUTHRIE RESEARCH INSTITUTE   (United States)

^c LENOX HILL HEART AND VASCULAR INSTITUTE   (United States)

^d Mid Carolina Cardiology   (United States)

^e MOSES CONE HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DETERIORATION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HEART REINFARCTION; HEART VENTRICLE REMODELING; HEART VENTRICULOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; SYSTOLIC BLOOD PRESSURE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEART INFARCTION; HEART STROKE VOLUME; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

CREATINE KINASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 27244435226     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2005.00058.x     Document Type: Article

References (18)

1. Pfeffer MA, Brauwald E. Ventricular remodeling after myocardial infarction: Experimental observations and clinical implications. Circulation 1990;81:1161-1172.
2. St. John Sutton M, Pfeffer MA, Plappert T, et al. for the SAVE Investigators. Quantitative two-dimensional electrocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. Circulation 1994;89:68-75.
3. Jeremy RW, Allman KC, Bautowich G, et al. Patterns of left ventricular dilation during the six months after myocardial infarction. J Am Coll Cardiol 1989;13:304-310.
4. Pfeffer MA, Pfeffer JM. Ventricular enlargement and reduced survival after myocardial infarction. Circulation 1987;75(Suppl. IV):IV-93-IV-97.
5. Bolognese L, Cerisano G, Buonamici P, et al. Influence of infarct-zone viability on left ventricular remodeling following acute myocardial infarction. Circulation 1997;96:3353-3359.
6. Grines CL, Cox DA, Stone GW, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999;341(26):1949-1955.
7. Gronenschild E, Janssen J, Tijdens F. CAAS. II. A second generation system for off-line and on-line quantitative coronary angiography. Cathet Cardiovasc Diagn 1994;33:61-75.
8. Ellis SG, Vandormael MG, Couley MJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: Implications for patient selection. Circulation 1990;82:1193-1202.
9. Lansky AJ, Popma JJ. Qualitative and quantitative angiography. In Topol EJ, ed. Textbook of Interventional Cardiology. 3rd ed. Philadelphia: WB Saunders, 1999, pp. 725-747.
10. Grines CL, Topol EJ, Califf RM, et al. Prognostic implications and predictors of enhanced regional wall motion of the noninfarct zone after thrombolysis and angioplasty therapy of acute myocardial infarction. Circulation 1989;80:245-253.
11. Gaudron P, Eilles C, Kufler I, et al. Progressive left ventricular dysfunction and remodeling after myocardial infarction: Potential mechanisms and early predictors. Circulation 1993;87:755-763.
12. Bolognese L, Neskovic AN, Parodi G, et al. Left ventricular remodeling after primary coronary angioplasty: Patterns of left ventricular dilation and long-term prognostic implications. Circulation 2002;106(18):2351-2357.
13. Persson H, Rythe'n-Alder E, Melcher A, et al. Metoprolol and xamoterol infarction study. Br Heart J 1995;74:140-148.
14. St. John Sutton M, Pfeffer MA, Moye L, et al. Survival and ventricular enlargement: SAVE trial. Circulation 1997;96:3294-3299.
15. ISIS-4 (4th International Study of Infarct Survival Collaborative Group). ISIS-4: A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-685.
16. GISSI Investigators. GISSI-3: Effect of lisinopril and transdermal glyceryl trinitrate singly and together on 6 week mortality and ventricular function after myocardial infarction. Lancet 1994;343:1115-1122.
17. Swedberg K, Held P, Kjekhus J, et al. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (Consensus II). N Engl J Med 1992;327:678-684.
18. Chinese Cardiac Study Collaborative Group. Oral captopril vs placebo among 13,634 patients with suspected acute myocardial infarction: Chinese cardiac study (CCS-1). Lancet 1995;343:686-687.